|
"yeh kun huei"的相關文件
顯示項目 36-45 / 140 (共14頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T09:42:01Z |
Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice
|
Lin, Wei-Hsiang;Yeh, Shiou-Hwei;Yang, Wan-Jen;Yeh, Kun-Huei;Fujiwara, Toshiyoshi;Nii, Aisuke;Chang, Stanley Shi-Chung;Chen, Pei-Jer; Lin, W.-H. and Yeh, S.-H. and Yang, W.-J. and Yeh, K.-H. and Fujiwara, T. and Nii, A. and Chang, S.S.-C. and Chen, P.-J.; 葉坤輝 ;葉秀慧 ;陳培哲; 葉坤輝 ;葉秀慧 ;陳培哲; Lin, Wei-Hsiang; PEI-JER CHEN; Yeh, Shiou-Hwei; Yeh, Shiou-Hwei; KUN-HUEI YEH; Yeh, Shiou-Hwei; SHIOU-HWEI YEH; Yang, Wan-Jen; Yeh, Kun-Huei; Yeh, Kun-Huei; Fujiwara, Toshiyoshi; Nii, Aisuke; Chang, Stanley Shi-Chung; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Pei-Jer |
| 臺大學術典藏 |
2018-09-10T09:41:58Z |
Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverse
|
Sung-Hsin Kuo and Hui-Jen Tsai and Wen-Hui Weng and Chi-Cheng Li and Kun-Huei Yeh and Li-Tzong Chen and Ann-Lii Cheng; Kuo, Sung-Hsin;Tsai, Hui-Jen;Weng, Wen-Hui;Li, Chi-Cheng;Yeh, Kun-Huei;Chen, Li-Tzong;Cheng, Ann-Lii; 郭頌鑫;鄭安理;葉坤輝; Kuo, Sung-Hsin; Sung-Hsin Kuo; Tsai, Hui-Jen; KUN-HUEI YEH; Weng, Wen-Hui; ANN-LII CHENG; Li, Chi-Cheng; Yeh, Kun-Huei; Chen, Li-Tzong; Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T09:22:43Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Lin, Yu-Lin;Liau, Jau-Yu;Yu, Shan-Chi;Ou, Da-Liang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Y.-L. and Liau, J.-Y. and Yu, S.-C. and Ou, D.-L. and Lin, L.-I. and Tseng, L.-H. and Chang, Y.-L. and Yeh, K.-H. and Cheng, A.-L.; 林亮音 ;曾麗慧 ;張逸良 ;林育麟 ;鄭安理 ;葉坤輝 ;歐大諒 ;尤善琦 ;廖肇裕; 林亮音 ;曾麗慧 ;張逸良 ;林育麟 ;鄭安理 ;葉坤輝 ;歐大諒 ;尤善琦 ;廖肇裕; Lin, Yu-Lin; LI-HUI TSENG; Lin, Yu-Lin; Liau, Jau-Yu; YIH-LEONG CHANG; JAU-YU LIAU; Yu, Shan-Chi; Ou, Da-Liang; DA-LIANG OU; Ou, Da-Liang; LIANG-IN LIN; Lin, Liang-In; Lin, Liang-In; Tseng, Li-Hui; KUN-HUEI YEH; Tseng, Li-Hui; Chang, Yih-Leong; YU-LIN LIN; Yeh, Kun-Huei; ANN-LII CHENG; Yeh, Kun-Huei; Cheng, Ann-Lii; Cheng, Ann-Lii; Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T09:16:02Z |
Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression
|
Hsu, Chiun;Shen, Ying-Chun;Cheng, Chia-Chi;Cheng, Ann-Lii;Hu, Fu-Chang;Yeh, Kun-Huei; Hsu, C. and Shen, Y.-C. and Cheng, C.-C. and Cheng, A.-L. and Hu, F.-C. and Yeh, K.-H.; 鄭安理 ;許駿 ;葉坤輝; Hsu, Chiun; KUN-HUEI YEH; Hsu, Chiun; Shen, Ying-Chun; ANN-LII CHENG; Shen, Ying-Chun; Cheng, Chia-Chi; Cheng, Chia-Chi; Cheng, Ann-Lii; Hu, Fu-Chang; Hu, Fu-Chang; Yeh, Kun-Huei; Yeh, Kun-Huei |
| 臺大學術典藏 |
2018-09-10T08:32:52Z |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan
|
Chen, J.-S. and Chao, Y. and Hsieh, R.-K. and Cheng, A.-L. and Chen, P.-M. and Chiou, T.-J. and Chao, T.-Y. and Yeh, K.-H. and Chen, L.-T. and Whang-Peng, J.; 陳仁熙;趙毅;鄭安理;陳博明;邱宗傑;趙祖怡;葉坤輝;陳立宗;彭汪嘉康; CHEN, JEN-SHI;CHAO, YEE;CHENG, ANN-LII;CHEN, PO-MIN;CHIOU, TZEON-JYE;CHAO, TSU-YI;YEH, KUN-HUEI;CHEN, LI-TZONG;WHANG-PENG, JACQUELINE; KUN-HUEI YEH; ANN-LII CHENG; CHEN, JEN-SHI; CHAO, YEE; CHENG, ANN-LII; CHEN, PO-MIN; CHIOU, TZEON-JYE; CHAO, TSU-YI; YEH, KUN-HUEI; CHEN, LI-TZONG; WHANG-PENG, JACQUELINE |
| 臺大學術典藏 |
2018-09-10T04:29:19Z |
Semiquinone Radical Intermediate in Catecholic Estrogen-Mediated Cytotoxicity and Mutagenesis: Chemoprevention Strategies with Antioxidants
|
Jao, Ping; Chen, Kai-Wei; Lin, Wei-Hsiang; Cheng, Ya-Wen; Chen, Ding-Shinn; Chen, Pei-Jer; Su, Tung-Hung; Yeh, Kun-Huei; Yeh, Shiou-Hwei; Mitchell, James B.; Russo, Angelo; DeGraff, William; Stein, William; Krishna, Murali C.; Chuang, Eric Y.; Samuni, Ayelet M.; Ni, Lin-Chun; ERIC YAO-YU CHUANG; Yeh, Shiou-Hwei; Yeh, Kun-Huei; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn et al. |
| 臺大學術典藏 |
2017-01-01 |
Irinotecan and oxaliplatin might provide equal benefit as adjuvant chemotherapy for patients with resectable synchronous colon cancer and liver-confined metastases: A nationwide database study
|
Yeh, Kun Huei; Lai, Mei Shu; Cheng, Ann Lii; Chen, Ho Min; Liang, Yi Hsin; Shao, Yu Yun |
| 國立成功大學 |
2016-02-01 |
Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy.
|
Chiang, Nai-Jung;Yeh, Kun-Huei;Chiu, Chang-Fang;Chen, Jen-Shi;Yen, Chueh-Chuan;Lee, Kuan-Der;Lin, Yu-Lin;Bai, Li-Yuan;Chen, Ming-Huang;Lin, Jen-Shi;Yang, Youngsen;Rau, Kun-Ming;Hsiao, Hui-Hua;Shan, Yan-Shen;Chen, Li-Tzong |
| 國立臺灣大學 |
2016 |
Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice
|
Lin, Wei-Hsiang; Yeh, Shiou-Hwei; Yeh, Kun-Huei; Chen, Kai-Wei; Cheng, Ya-Wen; Su, Tung-Hung; Jao, Ping; Ni, Lin-Chun; Chen, Pei-Jer; Chen, Ding-Shinn; 陳定信; 葉坤輝; 葉秀慧; 陳培哲 |
| 國立臺灣大學 |
2016 |
Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: association with distinct clinicopathological and molecular features and poor clinical outcome
|
Tsai, Jia-Huei; Liau, Jau-Yu; Lin, Yu-Lin; Tseng, Li-Hui; Lin, Liang-In; Yeh, Kun-Huei; Jeng, Yung-Ming; 鄭永銘; 林亮音; 曾麗慧; 林育麟; 葉坤輝; 蔡佳惠; 廖肇裕 |
顯示項目 36-45 / 140 (共14頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
